Arie Apel

822 total citations
28 papers, 420 citations indexed

About

Arie Apel is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Arie Apel has authored 28 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Arie Apel's work include Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Arie Apel is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Arie Apel collaborates with scholars based in Israel, United States and Italy. Arie Apel's co-authors include Maya Koren‐Michowitz, Odit Gutwein, Naomi Rahimi‐Levene, Ron Ram, Ofir Wolach, Yishai Ofran, Yael Bar‐On, Odelia Amit, Miri Zektser and David Shasha and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Arie Apel

28 papers receiving 419 citations

Peers

Arie Apel
Odelia Amit Israel
Lohith Gowda United States
Radwan Massoud Lebanon
Muhammad Junaid Tariq United States
Seied Asadollah Mousavi Iran
Kelly Walkovich United States
Mukul Aggarwal India
Patricia Walker Australia
Lynette Chee Australia
Sarah Bird United Kingdom
Odelia Amit Israel
Arie Apel
Citations per year, relative to Arie Apel Arie Apel (= 1×) peers Odelia Amit

Countries citing papers authored by Arie Apel

Since Specialization
Citations

This map shows the geographic impact of Arie Apel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arie Apel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arie Apel more than expected).

Fields of papers citing papers by Arie Apel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arie Apel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arie Apel. The network helps show where Arie Apel may publish in the future.

Co-authorship network of co-authors of Arie Apel

This figure shows the co-authorship network connecting the top 25 collaborators of Arie Apel. A scholar is included among the top collaborators of Arie Apel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arie Apel. Arie Apel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wolach, Ofir, Liat Shargian, Moshe Yeshurun, et al.. (2022). Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis. Annals of Hematology. 101(8). 1719–1726. 21 indexed citations
3.
Apel, Arie, et al.. (2022). Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still’s Disease. SHILAP Revista de lepidopterología. 9(4). 217–220. 10 indexed citations
4.
Gutwein, Odit, et al.. (2021). BNT162b2 COVID‐19 vaccine is significantly less effective in patients with hematologic malignancies. American Journal of Hematology. 96(10). 1195–1203. 106 indexed citations
5.
Ram, Ron, David Hagin, Tal Freund, et al.. (2021). Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study. Transplantation and Cellular Therapy. 27(9). 788–794. 94 indexed citations
6.
Apel, Arie, Yishai Ofran, Alexander Gural, et al.. (2021). Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice. American Journal of Hematology. 96(7). 790–795. 21 indexed citations
7.
Ganzel, Chezi, Ron Ram, Alexander Gural, et al.. (2020). Venetoclax is safe and efficacious in relapsed/refractory AML. Leukemia & lymphoma. 61(9). 2221–2225. 30 indexed citations
8.
Apel, Arie, Yishai Ofran, Ofir Wolach, et al.. (2020). Safety and efficacy of blinatumomab: a real world data. Annals of Hematology. 99(4). 835–838. 21 indexed citations
9.
10.
Gutwein, Odit, et al.. (2019). Prevalence of Paroxysmal Nocturnal Hemoglobinuria Clones in Myeloproliferative Neoplasm Patients: A Cross-Sectional Study. Clinical Lymphoma Myeloma & Leukemia. 19(12). 812–814. 5 indexed citations
11.
Jain, Salvia, Abigail Washington, Rebecca Karp Leaf, et al.. (2017). Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma. Molecular Cancer Therapeutics. 16(10). 2304–2314. 10 indexed citations
12.
Shouval, Roni, Joshua Fein, Ivetta Danylesko, et al.. (2017). Determinants for Oral Mucositis in Allogeneic Hematopoietic Stem Cell Transplantation: Prospective Evaluation and Risk Analysis. Blood. 130. 3239–3239. 1 indexed citations
13.
Bar‐Natan, Michal, Dina Stroopinsky, Katarina Luptakova, et al.. (2017). Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1. British Journal of Haematology. 176(6). 929–938. 23 indexed citations
14.
Jain, Salvia, Abigail Washington, Rebecca Karp Leaf, et al.. (2016). Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma. Blood. 128(22). 4175–4175. 1 indexed citations
15.
Pyzer, Athalia R., Dina Stroopinsky, Jacalyn Rosenblatt, et al.. (2016). MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs. Blood. 128(22). 2871–2871. 2 indexed citations
16.
17.
Koren‐Michowitz, Maya, Arie Apel, Noga Shem‐Tov, et al.. (2014). Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation. Annals of Hematology. 94(3). 375–378. 8 indexed citations
18.
Apel, Arie, Meirav Kedmi, Miriam Berkowicz, et al.. (2014). Outcome differences in patients with precursor B cell acute lymphocytic leukemia over time: a retrospective analysis.. PubMed. 16(4). 224–8. 1 indexed citations
19.
Apel, Arie, et al.. (2009). The serotonin syndrome: initial misdiagnosis.. PubMed. 11(6). 367–70. 15 indexed citations
20.
Hoppen, H.‐O., et al.. (1997). Specific measurement of canine thyrotropin for diagnosis of hypothyroidism in the dog. 78(1). 13–17. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Odelia Amit Breakdown of academic impact, for papers by Lohith Gowda Breakdown of academic impact, for papers by Radwan Massoud Breakdown of academic impact, for papers by Muhammad Junaid Tariq Breakdown of academic impact, for papers by Seied Asadollah Mousavi Breakdown of academic impact, for papers by Kelly Walkovich Breakdown of academic impact, for papers by Mukul Aggarwal Breakdown of academic impact, for papers by Patricia Walker Breakdown of academic impact, for papers by Lynette Chee Breakdown of academic impact, for papers by Sarah Bird
Rankless by CCL
2026